Pancreatic cancer – what is it?
Pancreatic cancer is a malignant tumour of the pancreas. Doctors also refer to this as pancreatic carcinoma. The pancreas has two vital functions for the human body: it produces the digestive juices necessary for the breakdown of food in the gut, and it produces the hormones insulin and glucagon, which regulate blood sugar levels. To fulfil these functions, the pancreas comprises two types of tissue: the exocrine (secreting outwards) and the endocrine (secreting inwards). Digestive juices are produced in the exocrine tissue and are transported to the gut via pancreatic ducts. The endocrine tissue contains hormone-producing cells that produce, for example, insulin and glucagon, which regulate blood sugar levels. Tumours can develop in both types of tissue, although the vast majority arise in the exocrine part of the pancreas. Experts refer to this as exocrine ductal adenocarcinoma. Pancreatic cancer is a relatively rare but particularly insidious disease. The risk of developing the disease increases with age. Symptoms tend to be rare in the early stages of the disease. This is also why most patients are not diagnosed until the disease has reached an advanced stage, and the prognosis is generally poor. As for treatment, this depends on the extent of the tumour and the patient’s general condition. Generally speaking, treatment options include surgical removal of the tumour, radiotherapy or chemotherapy.
Causes and risk factors
The exact causes of pancreatic cancer are not yet known. However, it is known that certain factors can increase the risk of developing the disease. These are:
- Smoking: According to estimates, smokers have a 3.5-fold increased risk of developing pancreatic cancer. When combined with heavy alcohol consumption, the risk increases further. Passive smoking also appears to be a risk factor.
- Alcohol consumption: Heavy alcohol consumption increases the risk of developing the disease by a factor of 2.5. When combined with smoking, the risk appears to increase further.
- Pre-existing conditions: People who have had stomach surgery, for example due to a stomach ulcer, have a three- to seven-fold increased risk. Other conditions that increase the risk of pancreatic cancer include, in particular, diabetes mellitus or pancreatitis (inflammation of the pancreas). Pancreatic cancer can also be caused by previous treatments for other tumours in the abdominal cavity.
- Diet: It is believed that frequent consumption of sugar, smoked or barbecued foods increases the risk of developing pancreatic cancer.
- Environmental factors: Frequent exposure to chemicals and toxins such as nickel, chromium, chlorinated hydrocarbons, herbicides, pesticides and solvents appears to increase the risk of developing the tumour.
- Genetics: It is estimated that two to three per cent of cases are attributable to a genetic predisposition
- Overweight (obesity)
Symptoms of the disease
In the early stages of the disease, there are often no noticeable symptoms or complaints. Pancreatic cancer frequently only becomes apparent once it is already at a more advanced stage. Possible early symptoms include:
- Pain in the upper abdomen or back
- Loss of appetite and unintentional weight loss
- Jaundice
- Steatorrhoea: stools that are lighter in colour, greasy, sticky or shiny
- Disruptions to insulin production: diabetes mellitus may develop
Please note: These rather non-specific symptoms may also occur in other abdominal conditions. Possible symptoms that may develop later include:
- non-specific pain and digestive problems
- Fluid build-up in the abdomen (ascites)
- Inflammation of the pancreas of unknown cause (pancreatitis)
- impaired blood clotting
Pancreatic cancer – diagnosis
To diagnose pancreatic cancer, the patient is asked during the medical history about the nature, duration and severity of their symptoms, as well as any previous illnesses and medications. Risk factors are also assessed, a clinical examination is carried out with particular attention to the abdomen, and a blood sample is taken to determine tumour markers. (Please note: Whilst a blood test for tumour markers such as CA 19-9 cannot confirm pancreatic cancer, the tumour marker provides important information for further medical management and the course of the disease.) Furthermore, an endoscopic ultrasound scan of the abdomen may be carried out. During this procedure, the doctor can take tissue samples, which are then examined histologically under a microscope for cells indicative of pancreatic cancer. Computed tomography (CT) and magnetic resonance imaging (MRI) are very effective at visualising the internal organs in the abdominal and thoracic cavities, the duct systems of the pancreas and gallbladder, the interior of the skull, and also enlarged lymph nodes. Endoscopic retrograde cholangiopancreatography (ERCP) is also sometimes used. This procedure allows the pancreatic and bile ducts to be filled with a contrast agent and visualised under X-ray guidance; any narrowings or blockages in the duct system may indicate the presence of a tumour in the pancreas. Bone scans and positron emission tomography (PET) may also be used to determine whether metastases and bone involvement are present.
Pancreatic cancer – treatment
A cure for pancreatic cancer is only possible through surgery. However, this is only an option for between 15 and 20 per cent of those affected, namely when the surrounding tissue is still cancer-free. Other treatments are designed to alleviate the patient’s symptoms and to slow down or halt the spread of the tumour. Surgery If the tumour is located in the head of the pancreas, the Kausch or Whipple procedure is performed. This involves removing the tumour, part of the pancreas and the stomach, the duodenum and the gallbladder along with the bile duct. In some cases, the entire pancreas must be removed. In such cases, the digestive system and food intake are significantly impaired after the operation, and the system must be surgically restored in a second stage of the operation. During the operation, neighbouring lymph nodes are also removed. If these are not affected by cancer cells, this indicates that the tumour has not yet spread. Chemotherapy Following the operation, chemotherapy using cytostatic drugs is usually administered. The drugs are intended to prevent the proliferation of cancer cells or to eliminate them. If surgery was not possible because the tumour was already at an advanced stage, chemotherapy is also administered. This is referred to as palliative chemotherapy, the aim of which is to prolong the survival of those affected and improve their quality of life. Radiotherapy In principle, radiotherapy is not generally recommended for pancreatic cancer and is usually only administered as part of controlled trials. It is usually used in combination with chemotherapy for patients with locally advanced pancreatic cancer who are not eligible for surgery. Radiotherapy can also alleviate symptoms such as tumour-related pain.
Other treatments Chemotherapy is usually administered in combination with a tyrosine kinase inhibitor. This blocks the growth factors of the cancer cells, thereby inhibiting their spread. Newer treatment approaches, such as targeted therapies or immunotherapies, have so far shown only limited success.
Pain management Many patients with pancreatic cancer suffer from pain. Like patients with other cancers, they require effective pain management under the supervision of a specialist. Follow-up care In many patients with pancreatic cancer, the cancer returns after some time. This is referred to as a recurrence. If only isolated cancerous lesions are present, it may be possible to attempt further surgery or radiotherapy. In any case, follow-up care for pancreatic cancer is very important, as this is the only way to detect any recurrence, side effects or complications from the treatments in good time. Follow-up examinations frequently involve ultrasound and/or computed tomography, as well as the measurement of tumour markers.